SCREENING FOR ADVANCED FIBROSIS AMONG ALASKA NATIVE PEOPLES WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

被引：0
|
作者：
Johnston, Janet [1 ]
Barbour, Youssef [1 ]
Townshend-Bulson, Lisa [2 ]
Desai, Kena [1 ]
Homan, Chriss [1 ]
Rhodes, Wileina [1 ]
McMahon, Brian [3 ]
机构：
[1] Alaska Nat Tribal Hlth Consortiu, Anchorage, AK USA
[2] Alaska Nat Tribal Consortium, Anchorage, AK USA
[3] Alaska Native Med Ctr, Anchorage, AK USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
748
引用
收藏
页码：S558 / S559
页数：2
相关论文
共 50 条
  • [41] Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
    Cherubini, Alessandro
    Della Torre, Sara
    Pelusi, Serena
    Valenti, Luca
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (12) : 1126 - 1136
  • [42] Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Scarpellini, Emidio
    Scarcella, Marialaura
    Tack, Jan F.
    Scarlata, Giuseppe Guido Maria
    Zanetti, Michela
    Abenavoli, Ludovico
    ANTIOXIDANTS, 2024, 13 (11)
  • [43] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421019
  • [44] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [45] Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study
    Baek, Ji Woo
    Yang, Yeun Soo
    Jung, Keum Ji
    Kimm, Heejin
    Kim, So Young
    Lee, Sunmi
    Jee, Sun Ha
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (12) : 2623 - 2629
  • [46] Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
    Noureddin, Nabil
    Copur-Dahi, Nedret
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S41 - S51
  • [47] Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis
    Tincopa, Monica A.
    Loomba, Rohit
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 287 - 299
  • [48] Molecular pathogenesis of metabolic dysfunction-associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis
    Saito, Takashi
    Tsuchishima, Mutsumi
    Tsutsumi, Mikihiro
    George, Joseph
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (12)
  • [49] Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race
    Bril, Fernando
    Gray, Meagan
    OBESITY, 2024, 32 (03) : 612 - 622
  • [50] Associations of Cannabis Use, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Liver Fibrosis in US Adults
    Wu, Yu
    Fang, Fei
    Fan, Xingliang
    Nie, Hongming
    CANNABIS AND CANNABINOID RESEARCH, 2024,
12345